Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature

BACKGROUND: Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymphohistiocytosis is a rare and often fatal syndrome of uncon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Perez, Jaime, Rodríguez-Perez, Ángel Ricardo, Díaz-Blázquez, María, Moreno-García, Victor, Dómine-Gómez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531226/
https://www.ncbi.nlm.nih.gov/pubmed/36195892
http://dx.doi.org/10.1186/s13256-022-03585-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531226/
https://www.ncbi.nlm.nih.gov/pubmed/36195892
http://dx.doi.org/10.1186/s13256-022-03585-3

Ejemplares similares